Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H13NO2 |
Molecular Weight | 179.2157 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)OCCCC1=CC=CC=C1
InChI
InChIKey=CAMYKONBWHRPDD-UHFFFAOYSA-N
InChI=1S/C10H13NO2/c11-10(12)13-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H2,11,12)
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/25727392Curator's Comment: description was created based on several sources, including
https://www.alibaba.com/product-detail/Phenprobamate-673-31-4-treat-muscle_472655828.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/25727392
Curator's Comment: description was created based on several sources, including
https://www.alibaba.com/product-detail/Phenprobamate-673-31-4-treat-muscle_472655828.html
Phenprobamate (3-phenylpropylcarbamate, Gamaquil, Isotonil) is a centrally acting muscle relaxant with mild sedative and anticonvulsant effects. Muscle relaxants can enhance and prolong the effect of narcotic drugs and enable to obtain same effect with a smaller amount of alcohol or illicit substance. Almost all of the centrally acting muscle relaxants have varying sedative effects on which their abuse potential mainly depends. Overdose is similar to barbiturates. Its mechanism of action is probably similar to meprobamate. Phenprobamate was previously used in humans as an anxiolytic, and is still sometimes used in general anesthesia and for treating muscle cramps and spasticity. Phenprobamate is still used in some European countries, but it has generally been replaced by newer drugs. Phenprobamate is metabolized by oxidative degradation of the carbamate group and ortho-hydroxylation of the benzene ring, and is eliminated in urine by the kidneys. Doses range from 400 to 800 mg, up to 3 times a day.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM03BA51
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
WHO-VATC |
QM03BA01
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
WHO-ATC |
M03BA01
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
WHO-ATC |
M03BA51
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
WHO-VATC |
QM03BA71
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
||
|
WHO-ATC |
M03BA71
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4770
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
50538
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL1079576
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
673-31-4
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
892
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
UJZ473TPS0
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
DB13354
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
PHENPROBAMATE
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
2137
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
211-606-1
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
C98239
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
DTXSID2046464
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
64270
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
m8640
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000082241
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
SUB09780MIG
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
C008837
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY | |||
|
44682
Created by
admin on Fri Dec 15 15:13:51 GMT 2023 , Edited by admin on Fri Dec 15 15:13:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY